Literature DB >> 19841068

TLS inhibits RNA polymerase III transcription.

Adelene Y Tan1, James L Manley.   

Abstract

RNA transcription by all the three RNA polymerases (RNAPs) is tightly controlled, and loss of regulation can lead to, for example, cellular transformation and cancer. While most transcription factors act specifically with one polymerase, a small number have been shown to affect more than one polymerase to coordinate overall levels of transcription in cells. Here we show that TLS (translocated in liposarcoma), a protein originally identified as the product of a chromosomal translocation and which associates with both RNAP II and the spliceosome, also represses transcription by RNAP III. TLS was found to repress transcription from all three classes of RNAP III promoters in vitro and to associate with RNAP III genes in vivo, perhaps via a direct interaction with the pan-specific transcription factor TATA-binding protein (TBP). Depletion of TLS by small interfering RNA (siRNA) in HeLa cells resulted in increased steady-state levels of RNAP III transcripts as well as increased RNAP III and TBP occupancy at RNAP III-transcribed genes. Conversely, overexpression of TLS decreased accumulation of RNAP III transcripts. These unexpected findings indicate that TLS regulates both RNAPs II and III and supports the possibility that cross-regulation between RNA polymerases is important in maintaining normal cell growth.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19841068      PMCID: PMC2798296          DOI: 10.1128/MCB.00884-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  80 in total

1.  An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF.

Authors:  V Y Stefanovsky; G Pelletier; R Hannan; T Gagnon-Kugler; L I Rothblum; T Moss
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

2.  Coupled in vitro synthesis and splicing of RNA polymerase II transcripts.

Authors:  S Ghosh; M A Garcia-Blanco
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

3.  Identification of an RNA binding specificity for the potential splicing factor TLS.

Authors:  A Lerga; M Hallier; L Delva; C Orvain; I Gallais; J Marie; F Moreau-Gachelin
Journal:  J Biol Chem       Date:  2000-11-29       Impact factor: 5.157

4.  The retinoblastoma tumor suppressor protein targets distinct general transcription factors to regulate RNA polymerase III gene expression.

Authors:  H A Hirsch; L Gu; R W Henry
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

5.  Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription.

Authors:  J E Sutcliffe; T R Brown; S J Allison; P H Scott; R J White
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Authors:  V T Nguyen; T Kiss; A A Michels; O Bensaude
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

7.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins.

Authors:  L Yang; L J Embree; D D Hickstein
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

9.  Different human TFIIIB activities direct RNA polymerase III transcription from TATA-containing and TATA-less promoters.

Authors:  L Schramm; P S Pendergrast; Y Sun; N Hernandez
Journal:  Genes Dev       Date:  2000-10-15       Impact factor: 11.361

10.  TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines.

Authors:  Ritsuko Fujii; Toru Takumi
Journal:  J Cell Sci       Date:  2005-11-29       Impact factor: 5.285

View more
  42 in total

1.  Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.

Authors:  Jozsef Gal; Jiayu Zhang; David M Kwinter; Jianjun Zhai; Hongge Jia; Jianhang Jia; Haining Zhu
Journal:  Neurobiol Aging       Date:  2010-07-31       Impact factor: 4.673

Review 2.  The role of FUS gene variants in neurodegenerative diseases.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

3.  FUS Regulates Activity of MicroRNA-Mediated Gene Silencing.

Authors:  Tao Zhang; Yen-Ching Wu; Patrick Mullane; Yon Ju Ji; Honghe Liu; Lu He; Amit Arora; Ho-Yon Hwang; Amelia F Alessi; Amirhossein G Niaki; Goran Periz; Lin Guo; Hejia Wang; Elad Elkayam; Leemor Joshua-Tor; Sua Myong; John K Kim; James Shorter; Shao-En Ong; Anthony K L Leung; Jiou Wang
Journal:  Mol Cell       Date:  2018-03-01       Impact factor: 17.970

4.  Molecular entrapment by RNA: an emerging tool for disrupting protein-RNA interactions in vivo.

Authors:  Tarjani N Shukla; Jane Song; Zachary T Campbell
Journal:  RNA Biol       Date:  2020-01-28       Impact factor: 4.652

5.  Genome wide array analysis indicates that an amyotrophic lateral sclerosis mutation of FUS causes an early increase of CAMK2N2 in vitro.

Authors:  Paolo Convertini; Jiayu Zhang; Pierre de la Grange; Lawrence J Hayward; Haining Zhu; Stefan Stamm
Journal:  Biochim Biophys Acta       Date:  2013-03-29

6.  FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns.

Authors:  Tadashi Nakaya; Panagiotis Alexiou; Manolis Maragkakis; Alexandra Chang; Zissimos Mourelatos
Journal:  RNA       Date:  2013-02-06       Impact factor: 4.942

Review 7.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

8.  Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.

Authors:  Marisa Kamelgarn; Jing Chen; Lisha Kuang; Alexandra Arenas; Jianjun Zhai; Haining Zhu; Jozsef Gal
Journal:  Biochim Biophys Acta       Date:  2016-07-25

9.  The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site.

Authors:  Xuehui Liu; Chunyan Niu; Jintao Ren; Jiayu Zhang; Xiaodong Xie; Haining Zhu; Wei Feng; Weimin Gong
Journal:  Biochim Biophys Acta       Date:  2012-11-28

10.  Lysine acetylation regulates the RNA binding, subcellular localization and inclusion formation of FUS.

Authors:  Alexandra Arenas; Jing Chen; Lisha Kuang; Kelly R Barnett; Edward J Kasarskis; Jozsef Gal; Haining Zhu
Journal:  Hum Mol Genet       Date:  2020-09-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.